Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Lung fibrosis is a life-threatening disease caused by overt or insidious inflammatory responses. However, the mechanism of tissue injury-induced inflammation and subsequent fibrogenesis remains unclear. Recently, we and other groups reported that Th17 responses play a role in amplification of the inflammatory phase in a murine model induced by bleomycin (BLM). Osteopontin (OPN) is a cytokine and extracellular-matrix-associated signaling molecule. However, whether tissue injury causes inflammation and consequent fibrosis through OPN should be determined. In this study, we observed that BLM-induced lung inflammation and subsequent fibrosis was ameliorated in OPNdeficient mice. OPN was expressed ubiquitously in the lung parenchymal and bone-marrow-derived components and OPN from both components contributed to pathogenesis following BLM intratracheal instillation. Th17 differentiation of CD4+ αβ T cells and IL-17-producing γδ T cells was significantly reduced in OPN-deficient mice compared to WT mice. In addition, Th1 differentiation of CD4+ αβ T cells and the percentage of IFN-γ-producing γδ T cells increased. T helper cell differentiation in vitro revealed that OPN was preferentially upregulated in CD4+ T cells under Th17 differentiation conditions. OPN expressed in both parenchymal and bone marrow cell components and contributed to BLM-induced lung inflammation and fibrosis by affecting the ratio of pathogenic IL-17/protective IFN-γ T cells.
Abstract
Lung fibrosis is a life-threatening disease caused by overt or insidious inflammatory responses. However, the mechanism of tissue injury-induced inflammation and subsequent fibrogenesis remains unclear. Recently, we and other groups reported that Th17 responses play a role in amplification of the inflammatory phase in a murine model induced by bleomycin (BLM). Osteopontin (OPN) is a cytokine and extracellular-matrix-associated signaling molecule. However, whether tissue injury causes inflammation and consequent fibrosis through OPN should be determined. In this study, we observed that BLM-induced lung inflammation and subsequent fibrosis was ameliorated in OPNdeficient mice. OPN was expressed ubiquitously in the lung parenchymal and bone-marrow-derived components and OPN from both components contributed to pathogenesis following BLM intratracheal instillation. Th17 differentiation of CD4+ αβ T cells and IL-17-producing γδ T cells was significantly reduced in OPN-deficient mice compared to WT mice. In addition, Th1 differentiation of CD4+ αβ T cells and the percentage of IFN-γ-producing γδ T cells increased. T helper cell differentiation in vitro revealed that OPN was preferentially upregulated in CD4+ T cells under Th17 differentiation conditions. OPN expressed in both parenchymal and bone marrow cell components and contributed to BLM-induced lung inflammation and fibrosis by affecting the ratio of pathogenic IL-17/protective IFN-γ T cells.
참고문헌 (40)
- Wynn, T. A., "Mechanisms of fibrosis:therapeutic translation for fibrotic disease", Nat. Med, 18, pp.1028~1040 (2012)
- Wynn, T. A., "Integrating mechanisms of pulmonary fibrosis", J. Exp. Med, 208, pp.1339~1350 (2011)
- Wick, G., "The immunology of fibrosis", Annu. Rev. Immunol, 31, pp.107~135 (2013)
- Lo Re, S., "IL-17A-producing gammadelta T Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis", J. Immunol, 184, pp.6367~6377 (2010)
- Sonnenberg, G. F., "Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A", J. Exp. Med, 207, pp.1293~12305 (2010)
- Wilson, M. S., "Bleomycin IL-1beta-mediated pulmonary fibrosis is IL-17A dependent", J. Exp. Med, 207, pp.535~552 (2010)
- Oh, K., "Epithelial transglutaminase 2 is needed for T cell interleukin-17production subsequent pulmonary inflammation fibrosis in bleomycin-treated mice", J. Exp. Med, 208, pp.1707~1719 (2011)
- Ishijima, M., "Enhancement of osteoclastic bone resorption suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin", J. Exp. Med, 193, pp.399~404 (2001)
- Wang, K. X., "Osteopontin: role in immune regulation stress responses", Cytokine Growth Factor Rev, 19, pp.333~345 (2008)
- Chakraborty, G., "Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth angiogenesis via autocrine paracrine mechanisms", Cancer Res, 68, pp.152~161 (2008)
- Ahmed, M., "Osteopontin:a potentially important therapeutic target in cancer", Expert Opin. Ther. Targets, 15, pp.1113~1126 (2011)
- Yamamoto, N., "Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis", J. Clin. Invest, 112, pp.181~188 (2003)
- Weber, G. F., "Receptor-liginteraction between CD44 osteopontin(Eta-1)", Science, 271, pp.509~512 (1996)
- Katagiri, Y. U., "CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility chemotaxis", Cancer Res, 59, pp.219~226 (1999)
- Kanayama, M., "Alpha9 integrin its ligands constitute critical joint microenvironments for development of autoimmune arthritis", J. Immunol, 182, pp.8015~8025 (2009)
- Morimoto, J., "Osteopontin;as a target molecule for the treatment of inflammatory diseases", Curr. Drug Targets, 11, pp.494~505 (2010)
- Diao, H., "Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases", Immunity, 21, pp.539~550 (2004)
- Chung, J. W., "Osteopontin promotes the development of natural killer cells from hematopoietic stem cells", Stem Cells, 26, pp.2114~2123 (2008)
- Diao, H., "Osteopontin regulates development function of invariant natural killer T cells", Proc. Natl. Acad. Sci. U. S. A, 105, pp.15884~15889 (2008)
- Weber, C. E., "Epithelial-mesenchymal transition, TGF-β, osteopontin in wound healing tissue remodeling after injury", J. Burn. Care Res, 33, pp.311~318 (2012)
- Brown, L. F., "Expression distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces", Mol. Biol. Cell, 3, pp.1169~1180 (1992)
- Ashizawa, N., "Osteopontin is produced by rat cardiac fibroblasts mediates A(II)-induced DNA synthesis collagen gel contraction", J. Clin. Invest, 98, pp.2218~2227 (1996)
- Liaw. L., "Altered wound healing in mice lacking a functional osteopontin gene (spp1)", J. Clin. Invest, 101, pp.1468~1478 (1998)
- Konno, S., "Role of osteopontin, a multifunctional protein, in allergy asthma", Clin. Exp. Allergy, 41, pp.1360~1366 (2011)
- Pardo, A., "Up-regulation profibrotic role of osteopontin in human idiopathic pulmonary fibrosis", PLoS Med, 2, pp.e251~ (2005)
- Kelly, M. M., "Cell-specific gene expression in patients with usual interstitial pneumonia", Am. J. Respir. Crit. Care Med, 174, pp.557~565 (2006)
- Takahashi, F., "Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis", Am. J. Respir. Cell Mol. Biol, 24, pp.264~271 (2001)
- Berman, J. S., "Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice", Am. J. Physiol. Lung Cell. Mol. Physiol, 286, pp.L1311~L1318 (2004)
- Shinohara, M. L., "Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells", Nat. Immunol, 7, pp.498~506 (2006)
- Cantor, H., "Regulation of T-helper-cell lineage development by osteopontin: the inside story", Nat. Rev. Immunol, 9, pp.137~141 (2009)
- Baroni G. S., "Interferon gamma decreases hepatic stellate cell activation extracellular matrix deposition in rat liver fibrosis", Hepatology, 23, pp.1189~1199 (1996)
- Giri, S. N., "Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice", Biochem. Med. Metab. Biol, 36, pp.194~197 (1986)
- Oldroyd, S. D., "Interferon-gamma inhibits experimental renal fibrosis", Kidney Int, 56, pp.2116~2127 (1996)
- Ashkar, S., "Eta-1(osteopontin) : an early component of type-1(cell-mediated)immunity", Science, 287, pp.860~864 (2000)
- Murugaiyan, G., "Identification of an IL-27", osteopontin axis in dendritic cells its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation, 2010, pp.107, 11495~11500
- Shinohara, M. L., "Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development : role of intracellular osteopontin", Immunity, 29, pp.68~78 (2008)
- Wynn, T. A., "Fibrotic disease the T(H)1", T(H)2 paradigm, 2004, pp.4, 583~594
- Braun, R. K., "IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury", Inflammation, 31, pp.167~179 (2008)
- Simonian, P. L., "Regulatory role of gammadelta T cells in the recruitment of CD4+ CD8+ T cells to lung subsequent pulmonary fibrosis", J. Immunol, 177, pp.4436~4443 (2006)
- Simonian, P. L., "γδT cells protect against lung fibrosis via IL-22", J. Exp. Med, 207, pp.2239~2253 (2010)